A Phase I/II, Single and Repeat Dose, Dose Escalation Study of AV0328 Administered to Healthy Adult Volunteers
Phase of Trial: Phase I/II
Latest Information Update: 16 Jun 2017
At a glance
- Drugs AV 0328 (Primary)
- Indications Bacterial infections; Staphylococcal infections
- Focus Adverse reactions
- Sponsors Alopexx Vaccine
- 29 Mar 2017 Status changed from not yet recruiting to recruiting.
- 02 Mar 2017 Planned initiation date changed from 1 Feb 2017 to 1 Mar 2017.
- 06 Jan 2017 Planned End Date changed from 1 Feb 2018 to 1 Oct 2018.